Results 111 to 120 of about 6,083,333 (340)

Inauguration of the proceedings

PSL Quarterly Review, 2005
A little more than a year after the death of Franco Modigliani, the Accademia Nazionale dei Lincei felt compelled to devote, in agreement with the Bank of Italy and its Governor, his partner in this world-renowned an international conference.
Giovanni Conso
doaj  

Proceedings of The Biochemical Society [PDF]

, 1963
J. Paterson, Biochemi8try, R Baron, D Bennett, J Casida, J Casida, M Eto, R Baron, D Davies, P Holland, M Rumens, M Eto, J Casida, T Eto, D Henschler, D Myers, M Smith, E Elvove, W Frazier, M Smith, E Elvove, P Valaer, W Frazier, G Malleroy, C Cooper, D Tapley, J Dingle, A Glauert, M Daniel, K Lucy, A Lehninger, T Slater, D Planterose   +32 more
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Imbalance of the public finance in the context of Keynesian and Non-Keynesian effects of fiscal policy limitation [PDF]

, 2016
CER Comparative European Research 2016 Proceedings | Research Track of the 5th Biannual CER Comparative European Research Conference International Scientific Conference for Ph.D.
Stawska, Joanna
core  

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Proceedings From the First Asia‐Oceania Research Organisation on Genital Infections and Neoplasia (AOGIN) Meeting [PDF]

, 2006
Sebastian Faro
openalex   +1 more source

Angles from $B$ Decays with Charm

, 2005
Proceedings of the CKM 2005 Workshop (WG5), UC San Diego, 15-18 March 2005.Comment: 62 pages, 55 figures.
Abe, K., Albert, J., Asner, D., Atwood, D., Bruinsma, M., Cavoto, G., Fleischer, R., Ganzhur, S., Gershon, T., Iyutin, B., Keum, Y. Y., Mannel, T., Miyabayashi, K., Neri, N., Petrov, A. A., Pierini, M., Polci, F., Rama, M., Ronga, F., Schune, M. H., Silvestrini, L., Soni, A., Sordini, V., Stocchi, A., Verderi, M., Voena, C., Wilkinson, G., Zupan, J.   +27 more
core   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Scientific Proceedings, Forty-sixth General Meeting of the Society of American Bacteriologists [PDF]

, 1946
Stephen Chapman, C. M. Downs, Szymon Kowal   +2 more
openalex   +1 more source